Clinical trial discovery
Find Clinical Trials
Search studies by condition, treatment, location, eligibility, or trial identifier.
Showing 1–11 of 11 trials
Active filters
Clinical trials found
Published and searchable clinical trials
Searching for clinical trials...
Recruiting
SynKIR-310 for Relapsed/Refractory B-NHL
NCT06544265
- Conditions
- Aggressive B-Cell Non-Hodgkin Lymphoma, B Cell Lymphoma, Blood Protein Disorders, +54 more
- Locations
-
- Colorado Blood Cancer Institute, part of Sarah Cannon Cancer Institute Denver, Colorado, United States
- Winship Cancer Institute of Emory University Atlanta, Georgia, United States
- The University of Kansas Cancer Center Fairway, Kansas, United States
- Rutgers Cancer Institute New Brunswick, New Jersey, United States
NCT06533579
- Conditions
- B-cell Acute Lymphoblastic Leukemia, Burkitt Lymphoma, Chronic Disease, +40 more
- Locations
-
- City of Hope Duarte, California, United States
- Valkyrie Clinical Trials Los Angeles, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- New York Medical College Valhalla, New York, United States
Recruiting
CD79b-19 CAR T Cells in Non-Hodgkin Lymphoma
NCT06026319
- Conditions
- Diffuse Large B Cell Lymphoma, Follicular Lymphoma, Grade 3b Follicular Lymphoma, +21 more
- Locations
-
- Massachusetts General Hospital Boston, Massachusetts, United States
NCT05934448
- Conditions
- Epstein-Barr Virus Positive Diffuse Large B-Cell Lymphoma, Primary Mediastinal Large B Cell Lymphoma, Primary Mediastinal Large B-Cell Lymphoma Recurrent, +3 more
- Locations
-
- Dana-Farber Cancer Institute Boston, Massachusetts, United States
- Memorial Sloan Kettering Cancer Center New York, United States
NCT04186520
- Conditions
- Central Nervous System Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +28 more
- Locations
-
- Medical College of Wisconsin and Froedtert Hospital Milwaukee, Wisconsin, United States
Enrolling by Invitation
CD19.20.22 CAR T-cells for Patients With Relapsed/Refractory B-Cell Lymphomas
NCT07168486
- Conditions
- B-cell Lymphoma, Chronic Disease, Chronic Lymphocytic Leukemia, +31 more
- Locations
-
- University of Maryland, Baltimore Baltimore, Maryland, United States
NCT04875195
- Conditions
- Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Lymphoma, +8 more
- Locations
-
- Lundquist Institute for Biomedical Innovation at Harbor-UCLA-Hematology and Medical Oncology ( Site Torrance, California, United States
- Tulane Medical Center ( Site 0110) New Orleans, Louisiana, United States
- Anne Arundel Medical Center-Anne Arundel Oncology and Hematology ( Site 0125) Annapolis, Maryland, United States
- Hospital Erasto Gaertner ( Site 1703) Curitiba, Paraná, Brazil
Active, Not Recruiting
First-in-Human (FIH) Trial in Patients With Relapsed, Progressive or Refractory B-Cell Lymphoma
NCT03625037
- Conditions
- Aggressive B-cell Non-Hodgkin Lymphoma (aNHL), Chronic Disease, DLBCL, +26 more
- Locations
-
- Arizona Mayo Clinic Phoenix, Arizona, United States
- University of California at San Francisco San Francisco, California, United States
- Colorado Blood Cancer Institute Denver, Colorado, United States
- H. Lee Moffitt Cancer Center and Research Institute Tampa, Florida, United States
Active, Not Recruiting
P-CD19CD20-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With B Cell Malignancies
NCT06014762
- Conditions
- DLBCL, DLBCL - Diffuse Large B Cell Lymphoma, DLBCL Arising From Follicular Lymphoma, +21 more
- Locations
-
- Loma Linda University Cancer Center Loma Linda, California, United States
- Cedars-Sinai Medical Center Los Angeles, California, United States
- Advent Health Orlando Orlando, Florida, United States
- Indiana University Indianapolis, Indiana, United States
Active, Not Recruiting
Optimizing Cellular and Humoral Immunity by Vaccinating With PCV13 Before and After CAR-T Therapy
NCT04745559
- Conditions
- Diffuse Large-Cell Lymphoma, Follicular Lymphoma, Hemic and Lymphatic Diseases, +14 more
- Locations
-
- Moffitt Cancer Center Tampa, Florida, United States
Active, Not Recruiting
Phase 1 Study of Autologous CD30.CAR-T in Relapsed or Refractory CD30 Positive Non-Hodgkin Lymphoma
NCT04526834
- Conditions
- Anaplastic Large Cell Lymphoma, Diffuse Large B Cell Lymphoma, Extranodal NK/T-cell Lymphoma, +17 more
- Locations
-
- City of Hope Duarte, California, United States
- Sarah Cannon Research Institute Nashville, Tennessee, United States
- Baylor College of Medicine Houston, Texas, United States
- The University of Texas MD Anderson Cancer Centre Houston, Texas, United States